Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-012122

SVP & Chief Accounting Officer sold 11,705 shares at $22.37 ($261,841)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thomsen Jillian B. SVP & Chief Accounting Officer 2021-02-16 Sale −11,705 $22.37 $261,841 164,552 D: show line 1 in the form
Open-market sales · 11,705 sh · avg $22.37 · $261,841
Loading xslF345X03/doc4.xml…